Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Net Income (2019 - 2025)

Historic Net Income for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to -$14.0 million.

  • Pulmonx's Net Income rose 137.79% to -$14.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.7 million, marking a year-over-year increase of 71.22%. This contributed to the annual value of -$56.4 million for FY2024, which is 731.23% up from last year.
  • Latest data reveals that Pulmonx reported Net Income of -$14.0 million as of Q3 2025, which was up 137.79% from -$15.2 million recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Net Income ranged from a high of -$10.2 million in Q3 2021 and a low of -$16.2 million during Q2 2023
  • Over the past 5 years, Pulmonx's median Net Income value was -$14.2 million (recorded in 2022), while the average stood at -$14.1 million.
  • As far as peak fluctuations go, Pulmonx's Net Income plummeted by 16375.65% in 2021, and later soared by 1322.19% in 2024.
  • Pulmonx's Net Income (Quarter) stood at -$13.0 million in 2021, then dropped by 9.89% to -$14.3 million in 2022, then increased by 2.77% to -$13.9 million in 2023, then increased by 5.41% to -$13.1 million in 2024, then fell by 6.24% to -$14.0 million in 2025.
  • Its Net Income was -$14.0 million in Q3 2025, compared to -$15.2 million in Q2 2025 and -$14.4 million in Q1 2025.